Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004-2006

Stacey A. Fedewa, Ruth Etzioni, W. Dana Flanders, Ahmedin Jemal, Elizabeth M. Ward

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Background: Previous studies documenting variations in severity of prostate cancer at diagnosis by race/ethnicity and insurance status have been limited to small sample sizes and patients ≥65 years of age. This study examines disease severity among patients ages 18 to 99 from the National Cancer Database (NCDB). Methods: Patients diagnosed between 2004 and 2006 with prostate cancer were selected from the NCDB (n = 312,339). We evaluated the association among three disease severity measures: prostate specific antigen (PSA) level, Gleason score 8 to 10, and clinical T-stage 3/4, by race/ethnicity and insurance while adjusting for sociodemographic and clinical factors. Results: Uninsured and Medicaid-insured patients had elevated PSA levels, higher odds of advanced Gleason score [uninsured odds ratio (OR), 1.97; 95% confidence interval (95% CI), 1.82-2.12; Medicaid OR, 1.67; 95% CI, 1.55-1.79], and advanced clinical T stage (uninsured OR, 1.85; 95% CI, 1.69-2.03; Medicaid OR, 1.49; 95% CI, 1.35-1.63) compared with privately insured patients. Black (OR, 1.19; 95% CI, 1.15-1.23), Hispanic (OR, 1.16; 95% CI, 1.10-1.23), and Asian patients (OR, 1.22; 95% CI, 1.24-1.43) had higher odds of advanced Gleason score and similar odds of advanced stage of disease relative to whites. Conclusion: Insurance status is strongly associated with disease severity among prostate cancer patients. Impact: Strong associations between insurance and disease severity may be related to lack of access to preventive services such as PSA screening and barriers to medical evaluation. Although the risks and benefits of PSA screening have not been fully elucidated, it is important that all men have the opportunity to be informed about this option and preventative medical services.

Original languageEnglish (US)
Pages (from-to)2437-2444
Number of pages8
JournalCancer Epidemiology Biomarkers and Prevention
Volume19
Issue number10
DOIs
StatePublished - Oct 1 2010
Externally publishedYes

Fingerprint

Insurance
Prostatic Neoplasms
Odds Ratio
Databases
Confidence Intervals
Prostate-Specific Antigen
Neoplasm Grading
Medicaid
Neoplasms
Insurance Coverage
Hispanic Americans
Sample Size

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004-2006. / Fedewa, Stacey A.; Etzioni, Ruth; Flanders, W. Dana; Jemal, Ahmedin; Ward, Elizabeth M.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 19, No. 10, 01.10.2010, p. 2437-2444.

Research output: Contribution to journalArticle

Fedewa, Stacey A. ; Etzioni, Ruth ; Flanders, W. Dana ; Jemal, Ahmedin ; Ward, Elizabeth M. / Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004-2006. In: Cancer Epidemiology Biomarkers and Prevention. 2010 ; Vol. 19, No. 10. pp. 2437-2444.
@article{4340a6a7e07449c1ae90c782061d0343,
title = "Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004-2006",
abstract = "Background: Previous studies documenting variations in severity of prostate cancer at diagnosis by race/ethnicity and insurance status have been limited to small sample sizes and patients ≥65 years of age. This study examines disease severity among patients ages 18 to 99 from the National Cancer Database (NCDB). Methods: Patients diagnosed between 2004 and 2006 with prostate cancer were selected from the NCDB (n = 312,339). We evaluated the association among three disease severity measures: prostate specific antigen (PSA) level, Gleason score 8 to 10, and clinical T-stage 3/4, by race/ethnicity and insurance while adjusting for sociodemographic and clinical factors. Results: Uninsured and Medicaid-insured patients had elevated PSA levels, higher odds of advanced Gleason score [uninsured odds ratio (OR), 1.97; 95{\%} confidence interval (95{\%} CI), 1.82-2.12; Medicaid OR, 1.67; 95{\%} CI, 1.55-1.79], and advanced clinical T stage (uninsured OR, 1.85; 95{\%} CI, 1.69-2.03; Medicaid OR, 1.49; 95{\%} CI, 1.35-1.63) compared with privately insured patients. Black (OR, 1.19; 95{\%} CI, 1.15-1.23), Hispanic (OR, 1.16; 95{\%} CI, 1.10-1.23), and Asian patients (OR, 1.22; 95{\%} CI, 1.24-1.43) had higher odds of advanced Gleason score and similar odds of advanced stage of disease relative to whites. Conclusion: Insurance status is strongly associated with disease severity among prostate cancer patients. Impact: Strong associations between insurance and disease severity may be related to lack of access to preventive services such as PSA screening and barriers to medical evaluation. Although the risks and benefits of PSA screening have not been fully elucidated, it is important that all men have the opportunity to be informed about this option and preventative medical services.",
author = "Fedewa, {Stacey A.} and Ruth Etzioni and Flanders, {W. Dana} and Ahmedin Jemal and Ward, {Elizabeth M.}",
year = "2010",
month = "10",
day = "1",
doi = "10.1158/1055-9965.EPI-10-0299",
language = "English (US)",
volume = "19",
pages = "2437--2444",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004-2006

AU - Fedewa, Stacey A.

AU - Etzioni, Ruth

AU - Flanders, W. Dana

AU - Jemal, Ahmedin

AU - Ward, Elizabeth M.

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Background: Previous studies documenting variations in severity of prostate cancer at diagnosis by race/ethnicity and insurance status have been limited to small sample sizes and patients ≥65 years of age. This study examines disease severity among patients ages 18 to 99 from the National Cancer Database (NCDB). Methods: Patients diagnosed between 2004 and 2006 with prostate cancer were selected from the NCDB (n = 312,339). We evaluated the association among three disease severity measures: prostate specific antigen (PSA) level, Gleason score 8 to 10, and clinical T-stage 3/4, by race/ethnicity and insurance while adjusting for sociodemographic and clinical factors. Results: Uninsured and Medicaid-insured patients had elevated PSA levels, higher odds of advanced Gleason score [uninsured odds ratio (OR), 1.97; 95% confidence interval (95% CI), 1.82-2.12; Medicaid OR, 1.67; 95% CI, 1.55-1.79], and advanced clinical T stage (uninsured OR, 1.85; 95% CI, 1.69-2.03; Medicaid OR, 1.49; 95% CI, 1.35-1.63) compared with privately insured patients. Black (OR, 1.19; 95% CI, 1.15-1.23), Hispanic (OR, 1.16; 95% CI, 1.10-1.23), and Asian patients (OR, 1.22; 95% CI, 1.24-1.43) had higher odds of advanced Gleason score and similar odds of advanced stage of disease relative to whites. Conclusion: Insurance status is strongly associated with disease severity among prostate cancer patients. Impact: Strong associations between insurance and disease severity may be related to lack of access to preventive services such as PSA screening and barriers to medical evaluation. Although the risks and benefits of PSA screening have not been fully elucidated, it is important that all men have the opportunity to be informed about this option and preventative medical services.

AB - Background: Previous studies documenting variations in severity of prostate cancer at diagnosis by race/ethnicity and insurance status have been limited to small sample sizes and patients ≥65 years of age. This study examines disease severity among patients ages 18 to 99 from the National Cancer Database (NCDB). Methods: Patients diagnosed between 2004 and 2006 with prostate cancer were selected from the NCDB (n = 312,339). We evaluated the association among three disease severity measures: prostate specific antigen (PSA) level, Gleason score 8 to 10, and clinical T-stage 3/4, by race/ethnicity and insurance while adjusting for sociodemographic and clinical factors. Results: Uninsured and Medicaid-insured patients had elevated PSA levels, higher odds of advanced Gleason score [uninsured odds ratio (OR), 1.97; 95% confidence interval (95% CI), 1.82-2.12; Medicaid OR, 1.67; 95% CI, 1.55-1.79], and advanced clinical T stage (uninsured OR, 1.85; 95% CI, 1.69-2.03; Medicaid OR, 1.49; 95% CI, 1.35-1.63) compared with privately insured patients. Black (OR, 1.19; 95% CI, 1.15-1.23), Hispanic (OR, 1.16; 95% CI, 1.10-1.23), and Asian patients (OR, 1.22; 95% CI, 1.24-1.43) had higher odds of advanced Gleason score and similar odds of advanced stage of disease relative to whites. Conclusion: Insurance status is strongly associated with disease severity among prostate cancer patients. Impact: Strong associations between insurance and disease severity may be related to lack of access to preventive services such as PSA screening and barriers to medical evaluation. Although the risks and benefits of PSA screening have not been fully elucidated, it is important that all men have the opportunity to be informed about this option and preventative medical services.

UR - http://www.scopus.com/inward/record.url?scp=77958078031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958078031&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-10-0299

DO - 10.1158/1055-9965.EPI-10-0299

M3 - Article

C2 - 20705937

AN - SCOPUS:77958078031

VL - 19

SP - 2437

EP - 2444

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 10

ER -